Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLiontrust Asset Management Regulatory News (LIO)

Share Price Information for Liontrust Asset Management (LIO)

Share Price is delayed by 15 minutes
Get Live Data
302.00    0.00 (0.00%)
Bid:
299.00
Ask:
306.00
Spread: 7.00 (2.341%)
Market Cap: £180.03m
LIO Live PriceLast checked at - London Stock Exchange

Intraday Liontrust Asset Management Share Chart

Directorate Change

18 Jul 2024 07:00

RNS Number : 8187W
Liontrust Asset Management PLC
18 July 2024
 

LEI: 549300XVXU6S7PLCL855

For immediate release

18 July 2024

 

Liontrust Asset Management Plc

("Liontrust" or the "Company")

Appointment of new Chair

 

Liontrust announces that Alastair Barbour, Non-executive Chair of the Company, will retire from the board of directors of the Company (the "Board") at the close of the Company's Annual General Meeting (the "AGM") on 19 September 2024. Accordingly, Mr Barbour will not seek re-election at the AGM. The Board thanks Mr Barbour for his outstanding leadership and service to the Company.

 

Liontrust announces that Luke Savage will be appointed as Non-executive Director and Chair of the Company with effect from 20 September 2024. Mr Savage will also serve as chair of the Nomination Committee.

 

Mr Savage is an experienced Non-executive Director and Chair, as the Chair of Chesnara plc from February 2020 to date and a Non-executive Director of Deutsche Numis, having held the position of Chair of Numis Corporation plc from 2022 to 2023. He previously served as a Non-executive Director of DWF Group plc and Liverpool Victoria Financial Services Ltd.

 

Mr Savage's career has also included senior roles in leading financial institutions such as Standard Life plc, where he was Group CFO, Lloyd's of London, Deutsche Bank AG and Morgan Stanley. He is a qualified Chartered Accountant (ACA from ICAEW).

 

John Ions, Chief Executive Officer, said "Alastair has made a significant contribution to Liontrust as a Non-executive Director and then Chair since 2019, with the Group's AuMA nearly doubling over the past five years. Alastair has provided great guidance and advice, and I would like to thank him for all the support he has provided.

 

We look forward to welcoming Luke as the new Chair as Liontrust seeks to continue to develop the business and ensure we are well positioned for the growth in the savings market. Luke has extensive experience across the financial services industry, including in pensions and asset management, and this will be hugely beneficial to Liontrust in the years ahead."

 

Alastair Barbour, Non-executive Chair, said: "I am proud to have been Chair of Liontrust. The Group has built a great business; one that is in strong financial health. This is based on the hard work and dedication of everyone at Liontrust and I thank them for their contribution.

 

I wish Luke all the very best as the new Chair from September. I will be watching closely, willing Liontrust on to further success, knowing that they can grow through their strong investment teams, distribution and brand. Luke has the breadth of experience, knowledge and ability to Chair Liontrust for its next phase of growth."

 

Luke Savage, incoming Non-executive Chair, added: "I thank the Board for the opportunity of succeeding Alastair as Chair. It is to Alastair's and their credit that Liontrust is such a strong business.

 

I have been impressed by the ambition and strategy of John Ions and Vinay Abrol, the talent they have in their teams and am confident that Liontrust can take advantage of the many opportunities that lie ahead."

 

Notes:

 

1. The appointment of Luke Savage was made by the Board on the recommendation of the Nomination Committee.

 

2. The Board has determined that Luke Savage will be an independent Non-executive Director on appointment in accordance with the UK Corporate Governance Code.

 

3. Luke Savage has been a director of the following listed companies in the last five years:

 

Current Directorships

Past Directorships

Chesnara plc

Numis Corporation plc

DWF Group plc

 

4. There are no additional details to disclose in respect Luke Savage's appointment under Listing Rule 9.6.13R.

 

For further information please contact:

 

Teneo (Tel: 020 7353 4200, Email: liontrust@teneo.com)

Tom Murray, Colette Cahill, Jessica Pine

 

Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: liontrust.co.uk)

Stephen Corbett: Head of Investor Relations

Simon Hildrey: Chief Marketing Officer

 

Singer Capital Markets (Tel: 020 7496 3000)

Corporate Broking: Charles Leigh-Pemberton

Corporate Finance: James Moat

 

Panmure Liberum (Tel: 020 7886 2500)

Corporate Broking: David Watkins

Corporate Advisory: Atholl Tweedie

 

HSBC Bank plc (Tel: 020 7991 8888)

Corporate Broking: Sam McLennan, James Hopton

Corporate Advisory: Alexander Paul

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPURCMUPCGCM
Date   Source Headline
3rd Feb 20263:23 pmRNSForm 8.3 - KITWAVE GROUP PLC
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20263:56 pmRNSForm 8.3 - KITWAVE GROUP PLC
2nd Feb 20267:05 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20263:22 pmRNSForm 8.3 -KITWAVE GROUP PLC
29th Jan 20263:19 pmRNSForm 8.3 - Auction Technology Group
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20262:45 pmRNSForm 8.3 - Oxford Biomedica Plc
28th Jan 20262:40 pmRNSForm 8.3 - Kitwave Group Plc
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20263:25 pmRNSForm 8.3 - Auction Technology Group Plc
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20262:08 pmRNSForm 8.3 - Oxford Biomedica Plc
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:40 pmRNSForm 8.3 - Auction Technology Group PLC
14th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTrading Statement
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20263:17 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20263:29 pmRNSHolding(s) in Company
2nd Jan 202611:08 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20254:00 pmRNSDirector/PDMR Shareholding
19th Dec 20254:00 pmRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20255:44 pmRNSForm 8.3 - INSPECS GROUP PLC
12th Dec 20255:27 pmRNSForm 8.3 - INSPECS GROUP PLC
11th Dec 20251:42 pmRNSForm 8.3 - INSPECS GROUP PLC
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20253:03 pmRNSForm 8.3 - INSPECS GROUP PLC
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20253:36 pmRNSForm 8.3 - INSPECS GROUP PLC
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20254:02 pmRNSForm 8.3 - ESSENSYS PLC
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.